electroCore Projects 26% Revenue Growth in 2025, Ends Year with $11.6M Cash
Event summary
- electroCore expects full-year 2025 revenue of $31.8–$32.0 million, up ~26% from 2024.
- Fourth-quarter 2025 revenue projected at $9.0–$9.2 million, a ~30% YoY increase.
- Cash position declined to $11.6 million by December 31, 2025, from $13.2 million in Q3.
- Company to provide detailed financial update in March 2026 earnings call.
The big picture
electroCore’s projected 26% revenue growth reflects strong demand for its non-invasive neuromodulation technologies, particularly in chronic pain management. However, the decline in cash reserves raises questions about its financial runway, especially as it continues to invest in product development and commercialization. The company’s ability to balance growth with cash management will be critical in the coming quarters.
What we're watching
- Revenue Sustainability
- Whether electroCore can maintain its 26% growth trajectory amid potential macroeconomic headwinds.
- Cash Burn Rate
- The pace at which electroCore’s cash reserves are depleting and its ability to secure additional funding.
- Product Diversification
- How the company’s expansion into wellness products like Truvaga and TAC-STIM impacts its core medical device business.
Related topics